Frontlight ResearchEarly access
Ulcerative colitis trials in Germany
31 of 38 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in GermanyA Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease
- Where
- Berlin, Remscheid, Tuebingen, Ulm
- Age
- 18 years and over
- People
- 54 worldwide
- Run by
- Mirador Therapeutics Inc.
See details and how to join2025-522001-38-00 - Phase 1Taking peopleA randomized, double-blind, placebo-controlled, single and multiple-dose-escalation, phase 1 study in healthy volunteers and patients with ulcerative colitis to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of GRT-001 (MONOlith trial)
- Where
- Berlin
- Age
- 18 years and over
- People
- 112
- Run by
- Granite Bio AG
See details and how to join2023-507547-11-00 - Phase 2Taking peopleA Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- Where
- Frankfurt am Main, Frankfurt Am Main, Kiel, Ludwigshafen am Rhein, Mannheim, Tuebingen, Ulm
- Age
- 18 years to 75 years
- People
- 192 worldwide
- Run by
- Takeda
See details and how to joinNCT06764615 · EU 2024-518914-18-00 - Phase 4Taking peopleEfficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed Moderate-to-severe Ulcerative Colitis
- Where
- Augsburg, Berlin, Dornstadt, Friedrichsthal, Halle (Saale), Hamburg, Hamm, Hannover, Iserlohn, Jerichow, Kassel, Kiel, Leipzig, Lueneburg, Magdeburg, Marburg, Pforzheim, Potsdam, Velbert
- Age
- 18 years to 75 years
- People
- 300 worldwide
- Run by
- University Hospital Schleswig-Holstein
See details and how to joinNCT07235904 · EU 2025-522585-72-00 - Phase 2Not yet taking people in GermanyMulti-center, single-arm, phase II clinical trial evaluating efficacy and in-vivo homing of adoptively transferred autologous ex-vivo expanded regulatory T cells in adults with ulcerative colitis
- Where
- Berlin, Erlangen
- Age
- 18 years and over
- People
- 30
- Run by
- Universitaetsklinikum Erlangen AöR
See details and how to join2025-520628-11-00 - No phaseTaking peopleTexture and Color Enhancement Imaging (TXI) for Inflammation Assessment in Patients With Inflammatory Bowel Diseases
- Where
- Ulm
- Age
- 18 years and over
- People
- 80
- Run by
- University of Ulm
See details and how to joinNCT06892990